Compare · TMO vs TRT
TMO vs TRT
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Trio-Tech International (TRT): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while TRT operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $174.52B, about 1637.4x TRT ($106.6M).
- Over the past year, TMO is up 14.9% and TRT is up 291.5% - TRT leads by 276.6 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 5 for TRT).
- TMO has more recent analyst coverage (25 ratings vs 0 for TRT).
- Company
- Thermo Fisher Scientific Inc
- Trio-Tech International
- Price
- $469.56-0.67%
- $10.41+0.00%
- Market cap
- $174.52B
- $106.6M
- 1M return
- -1.03%
- -10.22%
- 1Y return
- +14.92%
- +291.54%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- AMEX
- IPO
- 1998
- News (4w)
- 17
- 5
- Recent ratings
- 25
- 0
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Trio-Tech International
Trio-Tech International, together with its subsidiaries, provides manufacturing, testing, and distribution services to the semiconductor industry. The company's Testing Services segment offers stabilization bake, thermal shock, temperature cycling, mechanical shock, constant acceleration, gross and fine leak, electrical, static and dynamic burn-in, and vibration testing, as well as reliability lab and microprocessor equipment contract cleaning services. This segment also provides qualification testing services that test small samples of output from manufacturers for qualification of their processes and devices. Its Manufacturing segment manufactures front-end semiconductor test equipment, such as artic temperature controlled wafer chucks used for test, characterization, and failure analysis of semiconductor wafers and other components; and wet process stations for cleaning, rinsing, and drying semiconductor wafers, flat panel display magnetic disks, and other microelectronic substrates. This segment also manufactures back-end products comprising autoclaves and highly accelerated stress test equipment; burn-in equipment and boards; and component centrifuges and leak detection equipment. The company's Distribution segment distributes complementary products, including environmental chambers, handlers, interface systems, vibration systems, shaker systems, solderability testers, and other semiconductor equipment, as well as components, such as connectors, sockets, LCD display panels, and touch-screen panels. Its Real Estate segment invests in and rents real estate properties. The company primarily serves semiconductor chip manufacturers or testing facilities that purchase testing equipment. The company operates in the United States, Singapore, Malaysia, Thailand, and China. Trio-Tech International was founded in 1958 and is headquartered in Van Nuys, California.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)
Latest TRT
- Trio-Tech International Receives Additional $2.6 Million in Orders for Burn-In Boards Supporting Next-Generation AI GPU Platform
- Director Adelman Jason T exercised 110,094 shares at a strike of $3.05, increasing direct ownership by 275% to 150,094 units (SEC Form 4)
- Director Ting Hock Ming sold $286,380 worth of TRT Common Stock (17,200 units at $16.65), decreasing direct ownership by 12% to 131,044 units (SEC Form 4)
- Director Horowitz Richard M sold $1,221,770 worth of shares (67,500 units at $18.10), decreasing direct ownership by 9% to 664,784 units (SEC Form 4)
- Director Adelman Jason T exercised 39,750 shares at a strike of $2.25 and sold $818,325 worth of shares (49,975 units at $16.37), decreasing direct ownership by 20% to 40,000 units (SEC Form 4)
- Director Adelman Jason T sold $123,570 worth of shares (22,000 units at $5.62), decreasing direct ownership by 31% to 50,000 units (SEC Form 4)
- Trio-Tech International filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Trio-Tech International
- Trio-Tech Reports 124% Q3 Revenue Growth, Driven by Strong Semiconductor Reliability Testing Demand Supporting AI and Automotive Applications
- Trio-Tech International filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits